Two nonprofit groups in April, 2017 alleged that Monsanto
intentionally mislabeled its weed killer Round Up as "target[ing] an
enzyme found in plants but not in people or pets." The lawsuit charges
that Monsanto's statement is "false, deceptive and misleading" because
the enzyme targeted by glyphosate "in fact, is found in people and pets."
Beyond Pesticides and the Organic Consumers Association, through
their attorneys filed the lawsuit in Washington, DC, court under the
District of Columbia's Consumer Protection Procedures Act. The case is Beyond
Pesticides et al v Monsanto Co. et al. The company's lawyers in turn, allege that since the
Federal Insecticide Fungicide and Rodenticide Act (FIFRA) makes the U.S.
Environmental Protection Agency responsible for the accuracy of pesticide
labeling the case is preempted based on existing case law in which courts
have already held that the law precludes any state labeling requirements
different from FIFRA.
In addition to this suit there are a number
of suits and class actions against Monsanto alleging that glyphosate, Roundup’s active
ingredient, is carcinogenic and tied to cases of non-Hodgkin lymphoma — an
association Monsanto strongly disputes and that is also the topic of competing
findings of scientific groups assessing cancer risk.
Adding complications to these
cases is the recent Fresno Superior Court case in which the court held that the
Prop 65 listing by the state of California, as a carcinogen was proper. Judge
Kapetan in her ruling against Monsanto, allows California to proceed with the process
of listing glyphosate, the
active ingredient in Roundup, as a chemical "known to the state to cause
cancer" in accordance with the Safe Drinking Water and Toxic Enforcement
Act of 1986 under Prop 65. This listing will
result in the requirement that all such products, if sold in California, carry
a label warning against its alleged carcinogenic effect.